INSPIRNA
Live / Registered — Registered (as of 01 Oct 2024)
What this means for you
Registered since 01 Oct 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90706226
- Registration number
- 7523687
- Mark type
- Stylized text
- Filed
- 12 May 2021
- Published for opposition
- 05 Apr 2022
- Registered
- 01 Oct 2024
- Attorney of record
- JEFFREY J. ELLISON
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of cancer; cancer therapeutics, namely, anti-cancer preparations
- Class 042 — Scientific and technological services: Scientific research and development in the field of treatment of cancer
Owner
- INSPIRNA, INC., NEW YORK, NY, US
- INSPIRNA, INC., NEW YORK, NY, US
- INSPIRNA, INC., NEW YORK, NY, US
- Rgenix, Inc., New York, NY, US
Prosecution history
- 01 Oct 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 01 Oct 2024 — REGISTERED-PRINCIPAL REGISTER
- 27 Aug 2024 — EXPARTE APPEAL TERMINATED
- 26 Aug 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 26 Aug 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 17 Aug 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 17 Aug 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 16 Aug 2024 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 16 Aug 2024 — EX PARTE APPEAL-INSTITUTED
- 16 Aug 2024 — JURISDICTION RESTORED TO EXAMINING ATTORNEY
- 16 Aug 2024 — EXPARTE APPEAL RECEIVED AT TTAB
- 24 May 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 24 May 2024 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 26 Feb 2024 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 26 Feb 2024 — FINAL REFUSAL E-MAILED